[HTML][HTML] iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis

…, L Baldari, E Cassinotti, M Ghidini, B Galassi… - Mucosal …, 2023 - Elsevier
iNKT cells account for a relevant fraction of effector T-cells in the intestine and are considered
an attractive platform for cancer immunotherapy. Although iNKT cells are cytotoxic …

Coronavirus infection and immune system: An insight of COVID-19 in cancer patients

…, M Ghidini, C Bareggi, M Cattaneo, B Galassi… - Critical Reviews in …, 2020 - Elsevier
The novel coronavirus respiratory illness (COVID-19) is a public health emergency of global
concern. Patients with cancer are at high risk of infections, due to an overall …

[HTML][HTML] IDH signalling pathway in cholangiocarcinoma: from biological rationale to therapeutic targeting

M Salati, F Caputo, C Baldessari, B Galassi, F Grossi… - Cancers, 2020 - mdpi.com
Simple Summary Cholangiocarcinoma is among the most challenging cancers to treat,
associated with poor prognosis both in the early and advanced setting. In the last decade, a …

[HTML][HTML] Impact of BMI on survival outcomes of immunotherapy in solid tumors: a systematic review

…, M Cattaneo, F Barbin, C Bareggi, B Galassi… - International Journal of …, 2021 - mdpi.com
Growing research has focused on obesity as a prognostic factor during therapy with immune-checkpoint
inhibitors (ICIs). The role of body-mass index (BMI) in predicting response and …

[HTML][HTML] Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis

G Tomasello, M Ghidini, B Galassi, F Grossi… - Scientific Reports, 2022 - nature.com
Clinical observations have demonstrated that microsatellite instability-high (MSI-H) and/or
deficient MMR (dMMR) status are associated with favorable prognosis and no benefit from 5-…

[HTML][HTML] High-Salt Diet Exacerbates H. pylori Infection and Increases Gastric Cancer Risks

V Balendra, C Amoroso, B Galassi, J Esposto… - Journal of Personalized …, 2023 - mdpi.com
Gastric cancer ranks as the fifth-leading contributor to global cancer incidence and the fourth-highest
in terms of cancer-related mortality. Helicobacter pylori (H. pylori) infection leads to …

Metabolic disorders and the risk of cholangiocarcinoma

…, J Singh, W Tai, E Rijavec, B Galassi… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Cholangiocarcinoma (CCA) is a malignancy which arises from the biliary
epithelium. Carcinogenesis of CCA is mainly linked to aberrant glucose metabolism and creation …

[PDF][PDF] Cetuximab-induced acneiform eruption and the response to isotretinoin

…, AV Marzano, F Onida, E Alessi, B Galassi… - ACTA …, 2008 - academia.edu
Acta Derm Venereol 88 (boric acid solution 2% and mupirocin) was administered, with no
response. Thus, oral isotretinoin 30 mg daily for 20 days was given, inducing good …

[HTML][HTML] The role of positron emission tomography/computed tomography (PET/CT) for staging and disease response assessment in localized and locally advanced …

M Ghidini, M Vuozzo, B Galassi, P Mapelli… - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic cancer (PC) has a severe prognosis and even after radical
surgery, relapse rate is very high (70–80%). The impact of PET/CT in PC clinical management …

Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2–3 studies

…, A Indini, E Rijavec, C Bareggi, B Galassi… - Radiotherapy and …, 2021 - Elsevier
Introduction Patients with initially inoperable non-metastatic pancreatic cancer (PC) have a
poor prognosis, often similar to those with metastatic disease. Neoadjuvant chemotherapy (…